2023年欧洲心脏病大会(演讲PPT):降低LDL-c方面未满足的需求:实现目标的障碍和对创新目标的需求.pdfVIP

  • 0
  • 0
  • 约8.25千字
  • 约 17页
  • 2023-09-21 发布于湖北
  • 举报

2023年欧洲心脏病大会(演讲PPT):降低LDL-c方面未满足的需求:实现目标的障碍和对创新目标的需求.pdf

Unmet Needs in Lowering LDL-C: Barriers to Goal Attainment and Need for New Targets Stephen Nicholls @ProfSNicholls Disclosures • Research support: AstraZeneca, Amgen, Anthera, Eli Lilly, Esperion, Novartis, Cerenis, The Medicines Company, Resverlogix, InfraReDx, Roche, Sanofi- Regeneron and LipoScience • Consulting and honoraria: AstraZeneca, Akcea, Eli Lilly, Anthera, Omthera, Merck, Takeda, Resverlogix, Sanofi-Regeneron, CSL Behring, Esperion, Boehringer I

文档评论(0)

1亿VIP精品文档

相关文档